effect of 2% citric acid on control of spontaneous epistaxis in

Evaluation of the effect of 2% citric acid on control of spontaneous epistaxis in patients with spontaneous epistaxis referring to emergency ward

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2012091510843N1

Enrollment

200

Registered

2012-10-03

Start date

2012-04-04

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epistaxis. Epistaxis

Interventions

All the individuals will be administered 5 drops of Acid Citric 2% nasal drop in the involved nose..

Treatment - Drugs

All the individuals will be administered 5 drops of Acid Citric 2% nasal drop in the involved nose.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: (to have spontaneous epistaxis) Exclusion criteria: (to have a prior history of coagulopathy; trauma; vascular abnormalities)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Nasal bleeding. Timepoint: 5, 10 and 20 minutes after the instillation of the drops. Method of measurement: Physical examination by the physician.;Blood pressure. Timepoint: 2 minutes before and 5, 10 and 20 minutes after the instillation of the drops. Method of measurement: By the physician using a Mercury sphygmomanometer.;Pulse rate per minute. Timepoint: 2 minutes before and 5, 10 and 20 minutes after the instillation of the drops. Method of measurement: By the physician.	—

Measure

Time frame

Nasal bleeding. Timepoint: 5, 10 and 20 minutes after the instillation of the drops. Method of measurement: Physical examination by the physician.;Blood pressure. Timepoint: 2 minutes before and 5, 10 and 20 minutes after the instillation of the drops. Method of measurement: By the physician using a Mercury sphygmomanometer.;Pulse rate per minute. Timepoint: 2 minutes before and 5, 10 and 20 minutes after the instillation of the drops. Method of measurement: By the physician.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPeyman Moharramzadeh

Tabriz University of Medical Sciences

moharramzadep@tbzmed.ac.ir+98 41 1335 7310

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026